The stock of IntelliPharmaCeutics International Inc. (TSE:I) is a huge mover today! About 26,727 shares traded hands. IntelliPharmaCeutics International Inc. (TSE:I) has risen 35.38% since March 10, 2016 and is uptrending. It has outperformed by 29.77% the S&P500.
The move comes after 5 months negative chart setup for the $87.01M company. It was reported on Oct, 17 by Barchart.com. We have $3.10 PT which if reached, will make TSE:I worth $11.31 million less.
Another recent and important IntelliPharmaCeutics International Inc. (TSE:I) news was published by Twst.com which published an article titled: “Intellipharmaceutics International Inc.: Intellipharmaceutics Signs an …” on October 11, 2016.
IntelliPharmaCeutics International Inc is a Canada pharmaceutical firm specializing in the research, development and manufacture of controlled-release and targeted-release oral solid dosage drugs. The company has a market cap of $87.01 million. The Company’s Hypermatrix technology is a multidimensional controlled-release drug delivery platform that is applied to the development of a range of existing and new pharmaceuticals. It currently has negative earnings. It has developed several drug delivery systems and a pipeline of products and product candidates in therapeutic areas that include neurology, cardiovascular, gastrointestinal tract, diabetes and pain.
I Company Profile
Intelsat S.A., incorporated on July 18, 2011, operates in satellite services business. The Firm provides communications services to media companies, fixed and wireless telecommunications operators, data networking service providers for enterprise and mobile applications in the air and on the seas, multinational firms and Internet service providers (ISPs). The Firm is also a well-known provider of commercial satellite communication services to the United States government and other select military organizations and their contractors. The Firm focuses on business-to-business services, indirectly enabling enterprise, government and consumer applications through its customers. The Firm has activities in North America, Europe, Latin America and Caribbean, Africa and Middle East, and Asia Pacific.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.